Yi Mo, Master of public health, vice chief physician, major in vaccine clinical research. Working as vice director of Vaccine Clinical Research Institute of Guangxi Center for Disease Control and Prevention and as a member of Vaccine Clinical Research Committee of Chinese Preventive Medicine Association.
Wenjian Fang, master of biology, major in clinical trial research and management, chief of Department of medical affairs in Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd.
Hong Li, MD, major in microbiology and immunology, especially on respiratory pathogens. Research associate at National Institutes for Food and Drug Control.
Junji Chen, Master of public health, physician in charge, major in vaccine clinical research.
Xiaohua Hu, master of microbiology and immunology, major in microbiology and immunology, research Associate in Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd.
Bin Wang, MD, major in microbiology and immunology, especially on enteric pathogens. Research associate at National Institutes for Food and Drug Control.
Zhengli Feng, Bachelor of biotechnology, major in vaccine clinical trial research. Working in Vaccine Clinical Research at the Institute of Guangxi Center for Disease Control and Prevention.
Honghua Shi, Bachelor of preventive medicine, vice chief physician, major in disease prevention and control. Position as the director of Yongfu County Center for Disease Prevention and Control.
Ying He, MD, attending physician, major in vaccine clinical research. Position as the vice director of Yongfu County Center for Disease Control and prevention.
Dong Huang, master of public health, chief physician, major in vaccine clinical research and disease control management. Position as the director of the Center for Disease Control and prevention, Yizhou District, Hechi City, Guangxi, a member of the Vaccine clinical Research Committee of the Chinese Preventive Medicine Association and a director of the Guangxi Preventive Medicine Association.
Zhaojun Mo, MD, Director of the Vaccine Clinical Research Institute of Guangxi Center for Disease Control and Prevention, major in Vaccines clinical trial and as PI positions, managed more than 60 vaccine clinical trials since 2010 including the first EV71 inactive VACCINE in the world, Chinese first COVID-19 mRNA vaccine, HPV, PPV, etc.
Qiang Ye, PhD, major in microbiology and immunology, especially on respiratory pathogens, as a researcher at National Institutes for Food and Drug Control.
Lin Du, Prof., major in Vaccinology. Working on the vaccine developments against Shigella, Escherichia coli, Streptococcus pneumoniae, Meningococci, etc.
